
Research Paper: CRISPR-Cas9: a new and promising player in gene therapy

Authors: Lu Xiao-Jie, Xue Hui-Ying, Ke Zun-Ping, Chen Jin-Lian, Ji Li-Juan

Abstract:
First introduced into mammalian organisms in 2013, the RNA-guided genome editing tool CRISPR-Cas9 offers several advantages over conventional ones.

Original Source: https://pubmed.ncbi.nlm.nih.gov/25713109/

Note: This is a placeholder PDF. The original paper could not be automatically extracted.
Please visit the original source URL to access the full paper content.
    